Clinical Trial Update: A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis [Phase 4]

View source ↗

Summary

Prospective Phase 4 trial evaluating cyclophosphamide treatment for idiopathic retroperitoneal fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Retroperitoneal Fibrosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Idiopathic Retroperitoneal Fibrosis | Phase 4 | Status: UNKNOWN